Diabetes medicine sales in South Korea have demonstrated a steady upward trend from 2013 to 2023, growing from 2.8 units to 4.3 units. This represents an overall rise with minor year-on-year fluctuations. Notable growth years included 2018 with an 8.57% increase, whereas 2019 saw no growth. Since then, the growth has stabilized between 2.38% and 5.26%. The Compound Annual Growth Rate (CAGR) from 2018 to 2023 stood at 2.5%.
Predictions for the future suggest continuous growth with sales expected to reach 4.9 units by 2028. The forecasted CAGR for the next 5 years is 2.18%, translating into an 11.36% overall growth from 2023 to 2028.
Future trends to watch for include advancements in diabetes treatment technologies, potential shifts in healthcare policies, and demographic changes such as aging populations, which may further impact the demand for diabetes medications in South Korea.
Latest reports
US Diabetes Market Report- Q1 2025
The US Diabetes Market in Q1 2025 is characterized by a dynamic interplay of increasing diabetes prevalence, technological advancements, and regulatory shifts. With...
China Diabetes Market Report- Q1 2025
In the first quarter of 2025, the diabetes market in China continued its dynamic expansion, influenced by significant trends in digital diabetes management,...
Japan Diabetes Market Report- Q1 2025
The Japan diabetes market in the first quarter of 2025 is experiencing dynamic changes driven by technological advancements, regulatory shifts, and strategic corporate...
Germany Diabetes Market Report- Q1 2025
The Germany Diabetes Market in the first quarter of 2025 is marked by transformative trends and strategic developments in diabetes management and treatment....
India Diabetes Market Report- Q1 2025
The diabetes market in India continues to experience significant growth in Q1 2025, driven by the rising prevalence of Type 2 diabetes. This...
UK Diabetes Market Report- Q1 2025
The diabetes market in the UK is experiencing substantial growth in Q1 2025, driven by technological advancements, increased prevalence of diabetes, and evolving...
France Diabetes Market Report- Q1 2025
In the first quarter of 2025, the diabetes market in France demonstrated significant advancements and strategic shifts, driven by key industry players and...
Canada Diabetes Market Report- Q1 2025
The Canada diabetes market in Q1 2025 is characterized by significant advancements and strategic developments across various segments. The landscape is being reshaped...
Brazil Diabetes Market Report- Q1 2025
The first quarter of 2025 has witnessed significant developments in the Diabetes market in Brazil, marked by rising prevalence and transformative shifts in...
Italy Diabetes Market Report- Q1 2025
The Italian diabetes market in the first quarter of 2025 continues to show significant growth and innovation, driven by the rising prevalence of...
